Home Ingredients CavaCurmin® (Curcumin Gamma-Cyclodextrin — Wacker)
Anti-InflammatoryJoint Health

CavaCurmin® (Curcumin Gamma-Cyclodextrin — Wacker)

Curcuma longa
Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

CavaCurmin® is a high-bioavailability curcumin from Wacker in which turmeric curcuminoids are complexed with gamma-cyclodextrin, a ring-shaped carrier sugar that dramatically improves curcumin absorption. Ordinary curcumin is poorly absorbed, so the gamma-cyclodextrin complex is designed to deliver far more curcumin to the bloodstream for its antioxidant and anti-inflammatory effects.

Studied Dose About 500 mg of the complex per day; the bioavailability study compared standardized doses across formulations.
Active Compound Turmeric curcuminoids (curcumin) complexed with gamma-cyclodextrin to increase oral bioavailability.

Benefits

Greatly improved absorption

In a human bioavailability study, the gamma-cyclodextrin curcumin complex delivered substantially higher blood levels of curcuminoids than standard curcumin, addressing curcumin's biggest weakness.

Supported by Trial 1

Anti-inflammatory support

By getting more curcumin into circulation, the complex supports curcumin's well-known role in calming inflammatory signaling and oxidative stress.

Supported by Trial 1

Joint comfort

Higher curcumin exposure underpins the joint-comfort uses curcumin is traditionally taken for, since absorption is the limiting factor for ordinary turmeric.

Supported by Trial 1

Mechanism of action

1

Cyclodextrin solubilization

Gamma-cyclodextrin forms a host-guest complex around curcumin, keeping the molecule soluble and protected so more survives digestion and enters the blood.

2

NF-kB and antioxidant pathways

Once absorbed, curcumin downregulates NF-kB-driven inflammatory mediators and supports antioxidant enzyme systems.

Clinical trials

1
Curcumin Formulation Bioavailability — Human Study
PubMed

Human study analyzing the relative oral bioavailability of several innovative curcumin formulations, including a gamma-cyclodextrin complex. (Purpura et al. 2018, European Journal of Nutrition)

Healthy adults.

The gamma-cyclodextrin curcumin complex achieved markedly higher relative bioavailability of curcuminoids than unformulated curcumin, confirming the absorption advantage.

Side effects and drug interactions

Common Potential side effects

GENERALLY WELL-TOLERATED — curcumin is well tolerated even at higher absorbed levels.
Mild digestive upset is occasionally reported.
High doses may loosen stools in some people.

Important Drug interactions

Anticoagulants and antiplatelets — curcumin may add to bleeding risk; monitor.
Diabetes medication — curcumin may lower blood sugar; watch levels.
Drugs metabolized by the liver — curcumin can affect certain enzymes; consult a doctor.

More Anti-Inflammatory Ingredients

Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…
Anti-Inflammatory
Meriva® (Curcumin Phytosome — Indena)
Meriva® is a CURCUMIN PHYTOSOME® formulation developed by Indena (Italy) — using Indena's…
Cognitive
Longvida® Optimized Curcumin (Verdure Sciences)
Longvida® is a PATENTED CURCUMIN EXTRACT developed by Verdure Sciences using SLCP™ (Solid…

Explore Other Ingredients

Antioxidant
Dandelion Root
Dandelion root is one of the most widely used hepatic and diuretic herbs in Western botani…
Cognitive
Rhodiola Rosea
Rhodiola rosea is an adaptogenic herb from arctic and mountainous regions of Europe and As…
Antioxidant
Milk Thistle
Milk thistle, derived from the Silybum marianum plant, contains silymarin, a compound know…

Frequently asked questions about CavaCurmin® (Curcumin Gamma-Cyclodextrin — Wacker)

What is CavaCurmin® (Curcumin Gamma-Cyclodextrin — Wacker)?

CavaCurmin® is a high-bioavailability curcumin from Wacker in which turmeric curcuminoids are complexed with gamma-cyclodextrin, a ring-shaped carrier sugar that dramatically improves curcumin absorption.

What is the recommended dosage of CavaCurmin® (Curcumin Gamma-Cyclodextrin — Wacker)?

The clinically studied dose for CavaCurmin® (Curcumin Gamma-Cyclodextrin — Wacker) is About 500 mg of the complex per day; the bioavailability study compared standardized doses across formulations.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is CavaCurmin® (Curcumin Gamma-Cyclodextrin — Wacker) used for?

CavaCurmin® (Curcumin Gamma-Cyclodextrin — Wacker) is studied for greatly improved absorption, anti-inflammatory support, joint comfort. In a human bioavailability study, the gamma-cyclodextrin curcumin complex delivered substantially higher blood levels of curcuminoids than standard curcumin, addressing curcumin's biggest weakness.

Are there side effects from taking CavaCurmin® (Curcumin Gamma-Cyclodextrin — Wacker)?

Reported potential side effects may include: GENERALLY WELL-TOLERATED — curcumin is well tolerated even at higher absorbed levels. Mild digestive upset is occasionally reported. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Is CavaCurmin® (Curcumin Gamma-Cyclodextrin — Wacker) safe to take?

Whether CavaCurmin® (Curcumin Gamma-Cyclodextrin — Wacker) is safe depends on the dose, your overall health, and any medications you take. At studied doses, reported side effects can include: GENERALLY WELL-TOLERATED — curcumin is well tolerated even at higher absorbed levels. It may also interact with certain medications. CavaCurmin® (Curcumin Gamma-Cyclodextrin — Wacker) is not suitable for everyone — consult a healthcare provider before use if you are pregnant or breastfeeding, have a medical condition, or take prescription medications.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Purpura M, Lowery RP, Wilson JM, et al. Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects. Eur J Nutr. 2018;57(3):929-938..PubMedUsed to support: Human study confirming improved curcumin bioavailability from the gamma-cyclodextrin complex.